AS

Active Director Director DIN 09444167
DIN 09444167 First appointment Jan 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 2 historical roles
Total affiliations 7 Since Jan 2022
Shareholding value •••• Premium profile

About Anju Soni

Data last updated:

Anju Soni is a Director at Serge Pharma Private Limited (since 2022), Director at Aspin It Solutions Private Limited (since 2022) and Director at Ekadanta Mineral Water Private Limited (since 2026), and holds 2 more current directorships. The companies operate in Pharma, Information Technology and Food And Beverages. The 2 current companies with reported revenue have a combined latest revenue of ₹81.82 Cr; the largest is Serge Pharma Private Limited at ₹70.11 Cr (FY 2025). Earlier, Anju Soni was an Additional Director at Cedrus Broadcasting Private Limited (2023–2024) and Director at Nagraj Buildings Private Limited (from 2022).

DIN 09444167
Primary Designation Director
Industry Pharma
First Appointment 03 Jan 2022
Oldest Company Age 9 yrs
Largest company Serge Pharma Private Limited · ₹70.11 Cr (FY 2025)
Combined revenue ₹81.82 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Serge Pharma Private Limited U51909MP2017PTC043450
Director10 Feb 20222017₹70.11 Cr (FY 2025)Active
Aspin It Solutions Private Limited U72900MP2021PTC055666
Director03 Jan 20222021₹11.71 Cr (FY 2025)Active
Director01 Jan 20262017Active
Arpan Events India Private Limited U92190MP2021PTC058136
Director24 Mar 20252021Active
Designated Partner02 Feb 20252024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cedrus Broadcasting Private Limited U22300CT2022PTC013228
Additional Director25 Mar 20232022₹3.95 Cr (FY 2024)Active
Nagraj Buildings Private Limited U70200DL2022PTC407625
Director30 Nov 20222022Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Serge Pharma Private Limited
Aspin It Solutions Private Limited
Nagraj Buildings Private Limited
Ekadanta Mineral Water Private Limited
Premium access

Shareholding and investment profile for Anju Soni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anju Soni

Anju Soni currently holds 5 directorships: Serge Pharma Private Limited (Director, since 10 Feb 2022, revenue ₹70.11 Cr (FY 2025)); Aspin It Solutions Private Limited (Director, since 03 Jan 2022, revenue ₹11.71 Cr (FY 2025)); Ekadanta Mineral Water Private Limited (Director, since 01 Jan 2026); Arpan Events India Private Limited (Director, since 24 Mar 2025); Neomi Polymers Llp (Designated Partner, since 02 Feb 2025).

Anju Soni was first appointed on 03 Jan 2022 as Director at Aspin It Solutions Private Limited. The most recent appointment on record is 01 Jan 2026 at Ekadanta Mineral Water Private Limited.

The 2 current companies of Anju Soni that report revenue have a combined latest revenue of ₹81.82 Cr: Serge Pharma Private Limited ₹70.11 Cr (FY 2025); Aspin It Solutions Private Limited ₹11.71 Cr (FY 2025).

Anju Soni held 2 earlier board appointments: Cedrus Broadcasting Private Limited (Additional Director, 25 Mar 2023 to 17 Jan 2024); Nagraj Buildings Private Limited (Director, from 30 Nov 2022).

The current boards of Anju Soni's companies include Vijay Laxmi Soni (Serge Pharma Private Limited), Palak (Aspin It Solutions Private Limited), Anurag Soni (Ekadanta Mineral Water Private Limited), Avish Lalit Jain (Ekadanta Mineral Water Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available